Fisher syndrome associated with IgG anti-GQ(1b). Antibody following infection by a specific serotype of Campylobacter jejuni

Ophthalmology

Volumn 105, Issue 7, 1998, Pages 1281-1285

  Ohtsuka, Kenji ^a   Nakamura, Yasushi ^a   Hashimoto, Masato ^a   Tagawa, Yumi ^b   Takahashi, Masaki ^c   Saito, Kahiko ^c   Yuki, Nobuhiro ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY TITER; AREFLEXIA; ARTICLE; CAMPYLOBACTER JEJUNI; CASE REPORT; CEREBELLAR ATAXIA; CLINICAL FEATURE; DIPLOPIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOADSORPTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; OPHTHALMOPLEGIA; PRIORITY JOURNAL; SEROTYPE; SYNDROME;

EID: 0031685244     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)97034-8     Document Type: Article

References (32)

1. Fisher M. An usual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
2. Berlit P, Rakicky J. The Miller Fisher syndrome: review of the literature. J Clin Neuroophthalmol 1992;12:57-63.
3. Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology, vol. 5, ed. 4. Baltimore: Williams & Wilkins, 1991:4394-538.
4. Yuki N, Sato S, Tsuji S, et al. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci 1993;118:83-7.
5. 1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-9.
6. 1b antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-7.
7. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-3.
8. 1b IgG antibodies recognize surface epitopes on Campylobacter jejuni isolated from patients with Miller Fisher syndrome. Ann Neurol 1995;37:260-4.
9. Yuki N, Ichikawa H, Doi A. Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype. J Pediatr 1995;126:55-7.
10. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-44.
11. 1b peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-5.
12. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM, antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
13. Yuki N, Sato S, Fujimoto S, et al. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barre syndrome. Muscle Nerve 1992;15:968-9.
14. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barre syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglycosamine residues. Ann Neurol 1993;33:243-7.
15. Yuki N, Handa S, Tai T, et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barre syndrome. J Neurol Sci 1995;130:112-6.
16. Yuki N, Takahashi M, Tagawa Y, et al. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barre syndrome and Fisher's syndrome. Ann Neurol 1997;42:28-33.
17. 1b antibody in Fisher's syndrome. Neurology 1993; 43:414-7.
18. Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;12:732-7.
19. Lior H. Serotyping of Campylobacter jejuni and C. coli by slide agglutination based on heat-liable antigenic factors. In: Butzler JP, ed. Campylobacter Infection in Man and Animal. Boca: CRC Press, 1984:61-76.
20. 1b antibody from Fisher's syndrome: a new approach to treatment: Neurology 1996;46:1644-51.
21. Weintraub MI. External ophthalmoplegia, ataxia, and areflexia complicating acute infectious polyneuritis. Am J Ophthalmol 1977;83:355-7.
22. Keane JR. Tonic pupils with acute ophthalmoplegic polyneuritis. Ann Neurol 1977;2:393-6.
23. Okajima T, Imamura S, Kawasaki S, et al. Fisher's syndrome: a pharmacologic study of the pupils. Ann Neurol 1977;2:63-5.
24. Price RL, O'Conner PS, Rothner AD. Acute ophthalmoplegia, ataxia, and areflexia (Fisher syndrome) in childhood. Cleve Clin Q 1978;45:247-52.
25. Smith JL, Walsh FB. Syndrome of external ophthalmoplegia, ataxia, and areflexia (Fisher): ocular manifestations in acute idiopathic polyneuritis (Guillain-Barré syndrome): report of two cases. Arch Ophthalmol 1957;58:109-14.
26. Yuki N, Sato S, Tsuji S, et al. Human leukocyte antigens in Fisher's syndrome. Ann Neurol 1993;43:414-7.
27. Muller-Mohnssen H, Tippe A, Hillenkamp F, Unsold E. Is the rise of the action potential of the ranvier node controlled by a paranodal organ? Naturwissenschaften 1974;61:369-70.
28. Kotani M, Kawashima I, Ozawa H, et al. Immunohistochemical localization of major gangliosides in rat cerebellum. Proc Jpn Acad Ser B 1992;68:109-13.
29. Guerrant RL, Lahita RG, Winn WC, Jr, Roberts RB. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med 1978;65:584-92.
30. Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter jejuni infections. Epidemiol Rev 1983; 5:157-76.
31. Kaijser B, Sjogren E. Campylobacter strains in Sweden. Serotyping and correlation to clinical symptoms. Acta Pathol Microbiol Immunol Scand[B]1985;93:315-22.
32. Yuki N, Miyatake T, Ohsawa T. Beneficial effect of plasmapheresis on Fisher's syndrome. Muscle Nerve 1993;16:1267-8.